We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$9.56B
AUM Growth
+$286M
Cap. Flow
-$224M
Cap. Flow %
-2.34%
Top 10 Hldgs %
15.65%
Holding
748
New
32
Increased
258
Reduced
332
Closed
44

Top Buys

Rank Stock Value
1
PINC
Premier
PINC
+$16.6M
2
PZZA icon
Papa John's
PZZA
+$16.4M
3
ARCB icon
ArcBest
ARCB
+$15.6M
4
BDX icon
Becton Dickinson
BDX
+$15.5M
5
AHCO icon
AdaptHealth
AHCO
+$15.1M

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$59M
2
PRGS icon
Progress Software
PRGS
+$49.8M
3
IMGN
Immunogen Inc
IMGN
+$23M
4
DHR icon
Danaher
DHR
+$21.6M
5
HOG icon
Harley-Davidson
HOG
+$15.5M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Industrials 18.36%
3 Healthcare 16.52%
4 Financials 12.36%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCIT icon
601
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$389K ﹤0.01%
4,918
-585
-11% -$46.5K
EVR icon
602
Evercore
EVR
$12.4B
$386K ﹤0.01%
3,120
+200
+7% +$23K
SCZ icon
603
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$383K ﹤0.01%
6,489
-2,005
-24% -$120K
ELS icon
604
Equity Lifestyle Properties
ELS
$12.6B
$382K ﹤0.01%
5,707
BOH icon
605
Bank of Hawaii
BOH
$3.15B
$381K ﹤0.01%
9,248
ALNY icon
606
Alnylam Pharmaceuticals
ALNY
$27.5B
$380K ﹤0.01%
2,000
SCHD icon
607
Schwab US Dividend Equity ETF
SCHD
$103B
$380K ﹤0.01%
15,681
-2,205
-12% -$52.7K
OMCL icon
608
Omnicell
OMCL
$1.61B
$379K ﹤0.01%
5,144
-200
-4% -$13.5K
FAST icon
609
Fastenal
FAST
$54.7B
$378K ﹤0.01%
12,832
VAW icon
610
Vanguard Materials ETF
VAW
$2.95B
$373K ﹤0.01%
2,050
ITOT icon
611
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$372K ﹤0.01%
3,805
ALL icon
612
Allstate
ALL
$68B
$368K ﹤0.01%
3,371
VSS icon
613
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$367K ﹤0.01%
3,325
BR icon
614
Broadridge
BR
$17.8B
$366K ﹤0.01%
2,207
C icon
615
Citigroup
C
$222B
$364K ﹤0.01%
7,897
+395
+5% +$18.5K
LH icon
616
Labcorp
LH
$25B
$360K ﹤0.01%
1,734
+8
+0.5% +$1.55K
OTIS icon
617
Otis Worldwide
OTIS
$27.4B
$353K ﹤0.01%
3,971
-584
-13% -$49.2K
WMB icon
618
Williams Companies
WMB
$87.5B
$342K ﹤0.01%
10,485
-250
-2% -$7.5K
DFAC icon
619
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
$342K ﹤0.01%
12,585
-475
-4% -$12.2K
MOMO
620
Hello Group
MOMO
$885M
$340K ﹤0.01%
35,400
PHG icon
621
Philips
PHG
$25.7B
$340K ﹤0.01%
17,514
+259
+2% +$4.53K
PLD icon
622
Prologis
PLD
$135B
$336K ﹤0.01%
2,740
+100
+4% +$12.3K
HES
623
DELISTED
Hess
HES
$334K ﹤0.01%
2,454
UBER icon
624
Uber
UBER
$143B
$332K ﹤0.01%
7,700
+1,200
+18% +$44.6K
ET icon
625
Energy Transfer Partners
ET
$70.1B
$329K ﹤0.01%
25,897
+192
+0.7% +$2.43K

Similar funds

Segall Bryant & Hamill's Q2 2023 Portfolio in Review

As of Q2 2023, Segall Bryant & Hamill held 748 positions worth $9.56B, up 3.1% from $9.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q2 2023 filing shows 32 new, 258 increased, 332 reduced and 44 closed positions. Its largest new stake was Premier: 582,008 shares worth $16.1M. The largest sale was Unilever, an estimated $59M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Segall Bryant & Hamill's largest Q2 2023 buy was Premier: 582,008 shares worth $16.1M.
  • Segall Bryant & Hamill added most to Papa John's in Q2 2023, an estimated $16.4M increase.
  • Segall Bryant & Hamill's biggest Q2 2023 reduction was Progress Software, cutting an estimated $49.8M.
  • Segall Bryant & Hamill fully exited Unilever in Q2 2023, selling an estimated $59M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $9.56B portfolio in Q2 2023.
  • Segall Bryant & Hamill opened 32 new positions and closed 44 in Q2 2023.
  • Segall Bryant & Hamill's portfolio value rose 3.1% quarter-over-quarter to $9.56B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2023, filed 14 Aug 2023.